99 related articles for article (PubMed ID: 21040321)
1. An audit of platelet transfusion within the Wellington Cancer Centre.
Buhrkuhl DC; Karlsson MK; Carter JM
Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
[TBL] [Abstract][Full Text] [Related]
2. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion in hematology, oncology and surgery.
Wandt H; Schäfer-Eckart K; Greinacher A
Dtsch Arztebl Int; 2014 Nov; 111(48):809-15. PubMed ID: 25512006
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic platelet transfusion response in critically ill patients: a prospective multicentre observational study.
Reizine F; Le Marec S; Le Meur A; Consigny M; Berteau F; Bodenes L; Geslain M; McQuilten Z; Le Niger C; Huntzinger J; Seguin P; Thibert JB; Simon D; Reignier J; Egreteau PY; Tadié JM; Huet O; Asfar P; Ehrmann S; Aubron C
Crit Care; 2023 Sep; 27(1):373. PubMed ID: 37759268
[TBL] [Abstract][Full Text] [Related]
5. Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes.
Mo A; Wood E; Shortt J; Hu E; McQuilten Z
Eur J Haematol; 2023 Oct; 111(4):592-600. PubMed ID: 37452616
[TBL] [Abstract][Full Text] [Related]
6. The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial.
Kelly AM; Garner SF; Foukaneli T; Godec TR; Herbert N; Kahan BC; Deary A; Bakrania L; Llewelyn C; Ouwehand WH; Williamson LM; Cardigan RA
Blood; 2017 Jul; 130(2):214-220. PubMed ID: 28487294
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic platelet transfusion and risk of bleeding associated with ultrasound-guided central venous access in patients with severe thrombocytopenia.
Zarama V; Revelo-Noguera J; Quintero JA; Manzano R; Uribe-Buriticá FL; Carvajal DF; Ochoa LM; Valencia-Orozco A; Sánchez ÁI; Ospina-Tascón GA
Acad Emerg Med; 2023 Jun; 30(6):644-652. PubMed ID: 36587310
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Platelet Transfusion: Is There Evidence of Benefit, Harm, or No Effect?
Maier CL; Stanworth SJ; Sola-Visner M; Kor D; Mast AE; Fasano R; Josephson CD; Triulzi DJ; Nellis ME
Transfus Med Rev; 2023 Oct; 37(4):150751. PubMed ID: 37599188
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic Platelet Transfusions: Why Less Is More.
van der Staaij H; Stanworth SJ; Fustolo-Gunnink SF
Clin Perinatol; 2023 Dec; 50(4):775-792. PubMed ID: 37866847
[TBL] [Abstract][Full Text] [Related]
10. Use of platelet transfusions and tranexamic acid in patients with myelodysplastic syndromes: A clinical practice survey.
Mo A; Weinkove R; Wood EM; Shortt J; Johnston A; McQuilten ZK;
Eur J Haematol; 2024 Apr; 112(4):621-626. PubMed ID: 38123137
[TBL] [Abstract][Full Text] [Related]
11. Thrombocytopenia and bleeding in myelosuppressed transfusion-dependent patients: a simulation study exploring underlying mechanisms.
Middelburg RA; Kerkhoffs JH; van der Bom JG
Clin Epidemiol; 2018; 10():401-411. PubMed ID: 29692632
[TBL] [Abstract][Full Text] [Related]
12. Platelet transfusions in adult thrombocytopenic ICU patients: Protocol for a sub-study of the PLOT-ICU cohort.
Anthon CT; Pène F; Perner A; Azoulay E; Puxty K; Van De Louw A; Chawla S; Castro P; Povoa P; Coelho L; Metaxa V; Kochanek M; Liebregts T; Kander T; Sivula M; Møller MH; Russell L
Acta Anaesthesiol Scand; 2024 Mar; 68(3):434-440. PubMed ID: 38115558
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic versus restrictive platelet transfusion strategy in patients with haematological malignancies in the ICU setting, a propensity-score analysis.
Berenger JB; Saillard C; Sannini A; Servan L; Gonzalez F; Faucher M; de Guibert JM; Hospital MA; Bisbal M; Chow-Chine L; Mokart D
J Crit Care; 2024 May; 83():154817. PubMed ID: 38805833
[TBL] [Abstract][Full Text] [Related]
14. Pre-procedural platelet transfusion thresholds in hospitalised children - Protocol for a scoping review.
Holst LB; Afshari A; Møller MH; Russell L
Acta Anaesthesiol Scand; 2021 Apr; 65(4):558-561. PubMed ID: 33215692
[TBL] [Abstract][Full Text] [Related]
15. T-TAS
Samanbar S; Piñeyroa JA; Moreno-Castaño AB; Pino M; Torramadé-Moix S; Martinez-Sanchez J; Lozano M; Sanz C; Escolar G; Diaz-Ricart M
Blood Transfus; 2024 Mar; 22(2):166-175. PubMed ID: 38063791
[TBL] [Abstract][Full Text] [Related]
16. Risk and adverse clinical outcomes of thrombocytopenia among patients with solid tumors-a Danish population-based cohort study.
Adelborg K; Veres K; Horváth-Puhó E; Clouser M; Saad H; Sørensen HT
Br J Cancer; 2024 May; 130(9):1485-1492. PubMed ID: 38448749
[TBL] [Abstract][Full Text] [Related]
17. Platelet Transfusions: The Good, the Bad, and the Ugly.
Blumberg N; Asante AA; Nguyen PT; Heal JM
Anesth Analg; 2024 May; 138(5):921-924. PubMed ID: 38621279
[No Abstract] [Full Text] [Related]
18. The ongoing dilemma of prophylactic platelet transfusions pre-procedure and the development of evidence-based recommendations.
Stanworth SJ; Shah A; Doidge J; Watkinson P;
Transfus Med; 2023 Oct; 33(5):428-430. PubMed ID: 37712550
[No Abstract] [Full Text] [Related]
19. Prophylactic platelet transfusions in critical care: How low can you go?
Shah A; Stanworth SJ; Doidge JC; Watkinson PJ
J Intensive Care Soc; 2024 May; 25(2):123-127. PubMed ID: 38737301
[No Abstract] [Full Text] [Related]
20. How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa.
Ddungu H; Krantz EM; Kajja I; Naluzze S; Nabbanja H; Nalubwama F; Phipps W; Orem J; Kiwanuka N; Wald A
PLoS One; 2019; 14(2):e0211648. PubMed ID: 30726290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
